EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to determine whether Eplerenone reduces atrial fibrillation (AF) recurrences within the first 8 weeks after electrical cardioversion of persistent AF.
Epistemonikos ID: 47c3db235dbc1ce53619ccc1938298d4d4810a0a
First added on: May 04, 2024